作为首批在美国境内独立开展创新型肿瘤免疫治疗研究的中国药企之一，复宏汉霖始终以科学证据为核心，通过符合国际标准的临床实践与本土化开发，推动精准治疗策略的落地，为全球患者提供更加可负担、可及且贴合临床需求的创新治疗选择。

编者按：中枢神经系统（CNS）疾病由于病理机制复杂，且药物入脑受到血脑屏障（BBB）的限制，一直被认为是药物研发领域的重大挑战。尽管困难重重，但FDA已在CNS领域先后批准多款小分子药物的临床批件或上市，凸显了小分子疗法在CNS治疗中的重要作用。与此 ...

在机器人学习领域，提升基于生成式模型的控制策略（Policy）的性能通常意味着投入巨额成本进行额外的数据采集和模型训练，这极大地限制了机器人能力的快速迭代与升级。面对模型性能的瓶颈，如何在不增加训练负担的情况下，进一步挖掘并增强现有策略的潜力？

In the upcoming 15th Five-Year Plan period (2026-2030), China will continue its efforts in the field of space exploration. The Chang'e-7 and Chang'e-8 missions are scheduled for 2026 and 2028, ...

UNITED NATIONS, Oct. 16 (Xinhua) -- A whole convoy of aid trucks from the World Food Programme has managed to get to a warehouse in Gaza without being looted, and there has been a dramatic drop in ...

Hailing his keynote speech as a call to carry forward the spirit of the Beijing World Conference on Women and deepen global cooperation, observers worldwide said Xi's new proposals have charted a new ...

Like Xie, many Chinese travelers are combining sports and leisure this year. During the eight-day National Day and Mid-Autumn Festival holiday, which began on October 1, sporting events nationwide ...